Xenetic Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Xenetic Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2011 to Q2 2024.
  • Xenetic Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.27M, a 21.2% decline year-over-year.
  • Xenetic Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$4.7M, a 12% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.13M, a 36.9% increase from 2022.
  • Xenetic Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$6.55M, a 16.1% decline from 2021.
  • Xenetic Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$5.65M, a 48.2% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.7M -$1.27M -$223K -21.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$4.47M -$1.2M -$339K -39.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$4.13M -$1.17M +$311K +21% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$4.45M -$1.06M -$252K -31.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$4.19M -$1.05M +$1.62M +60.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$5.82M -$857K +$737K +46.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$6.55M -$1.48M +$359K +19.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$6.91M -$804K +$547K +40.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$7.46M -$2.67M -$1.57M -141% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$5.89M -$1.59M -$248K -18.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$5.65M -$1.84M -$642K -53.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$5M -$1.35M +$6.21M +82.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$11.2M -$1.11M -$153K -16% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$11.1M -$1.35M -$167K -14.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$10.9M -$1.2M -$29.8K -2.55% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$10.9M -$7.56M +$1.34M +15.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$12.2M -$954K +$424K +30.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$12.6M -$1.18M +$148K +11.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$12.8M -$1.17M +$469K +28.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$13.2M -$8.9M -$7.09M -391% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$6.16M -$1.38M +$649K +32% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$6.81M -$1.33M +$495K +27.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$7.3M -$1.64M -$6.08M -137% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$1.22M -$1.81M +$443K +19.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.66M -$2.03M +$893K +30.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$2.55M -$1.82M +$1.04M +36.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$3.6M $4.45M +$4.84M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$8.43M -$2.26M +$216K +8.74% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$8.65M -$2.92M +$44.9M +93.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$53.5M -$2.87M +$706K +19.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$54.2M -$391K +$3.24M +89.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$57.4M -$2.47M +$2.85M +53.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$60.3M -$47.8M -$46.6M -4146% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$13.6M -$3.57M -$1.14M -46.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$12.5M -$3.63M +$676K +15.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$13.2M -$5.32M -$2.14M -67.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$11M -$1.13M +$1.63M +59.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$12.7M -$2.43M +$1.63M +40.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$14.3M -$4.3M -$4.22M -5118% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$10.1M -$3.18M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$2.76M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$4.06M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 -$82.5K -$68K -470% Sep 1, 2013 Nov 30, 2013 10-Q 2014-01-10
Q4 2012 -$14.5K +$3.69K +20.3% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-10
Q4 2011 -$18.2K Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.